American Society of Clinical Oncology (ASCO) 2012 Annual Meeting

American Society of Clinical Oncology (ASCO) 2012 Annual Meeting
+ show speakers and program
Friday, June
1:00 PM — 2:15 PM
Education Sessions

Controversies in Indolent Lymphoma

Sonali M. Smith, MD—Chair
The University of Chicago
Gilles A. Salles, MD, PhD
Hospices Civils de Lyon and Universite de Lyon
Ajay K. Gopal, MD
University of Washington/Fred Hutchinson Cancer Research Center

The Cost of Lung Cancer Care: Screening, Personalized Medicine, and Palliative Care

Natasha B. Leighl, MD, FRCPC—Chair
Princess Margaret Hospital
Bernardo Haddock Lobo Goulart, MD
Seattle Cancer Care Alliance/Fred Hutchinson Cancer Research Center
Craig Earle, MD
Institute for Clinical Evaluative Sciences

Uterine Sarcoma: Challenging Cases for the Interdisciplinary Team

Martee Leigh Hensley, MD, MSc--Chair
Memorial Sloan-Kettering Cancer Center
Anuja Jhingran, MD
University of Texas M. D. Anderson Cancer Center
John Patrick Curtin, MD
New York University School of Medicine

Meet the Professor Session

BRCA Testing and PARP Inhibitors in the Treatment of Breast Cancer (M05)

Mark E. Robson, MD
Memorial Sloan-Kettering Cancer Center

1:00 PM —
3:15 PM


Extended Education Sessions

Cancer Prevention for Cancer Survivors

Lois B. Travis, MD, ScD—Chair
University of Rochester School of Medicine and Dentistry
James M. Allan, DPhil
Northern Institute for Cancer Research
Mark Norman Levine, MD
McMaster University
Andrea K. Ng, MD, MPH
Brigham and Women's Hospital and Harvard Medical School
Wendy Demark-Wahnefried, PhD, RD
University of Alabama at Birmingham
Marie Wood, MD
University of Vermont

From Discovery to Standards of Care in Clinical Trials of Head and Neck Cancer

Ezra E.W. Cohen, MD—Chair
The University of Chicago
David Sidransky, MD
The Johns Hopkins University
Quynh-Thu Le, MD
Stanford University Medical Center
Robert L. Ferris, MD, PhD
University of Pittsburgh Cancer Institute
Jill Gilbert, MD
Vanderbilt Medical Center

On the Shoulders of Giants: Historical Perspectives on Melanoma--Immunotherapy and Molecular Targeted Therapy

Albert C. Lockhart, MD—Chair
Siteman Cancer Center, Washington University School of Medicine
Jeffrey Alan Sosman, MD
Vanderbilt University Medical Center
Paul B. Chapman, MD
Memorial Sloan-Kettering Cancer Center
Christine Marie Lovly, MD, PhD
Vanderbilt Ingram Cancer Center
Marjorie Glass Zauderer, MD, MS
Memorial Sloan-Kettering Cancer Center

1:00 PM — 4:00 PM


Extended Education Session

Maintenance of Certification and Lifelong Learning Workshop (MOC)

Nina J. Karlin, MD—Chair
Mayo Clinic
Mark A. Socinski, MD
University of Pittsburgh Medical Center, UPMC Cancer Pavilion
Jeffrey M. Miller, MD
Olive View UCLA Medical Center

1:00 PM — 5:00 PM


Extended Education Session

2012 Grant Writing Workshop Program: Basic Grant Writing and Grant Writing Skills

Charles M. Rudin, MD, PhD—Co-Chair
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Eric Jay Small, MD—Co-Chair
University of California, San Francisco
Jennifer C. King, PhD
Conquer Cancer Foundation of ASCO
Susan Blaney, MD
Texas Children's Cancer Center
Heidi Nelson, MD
Mayo Clinic
Mary L. Disis, MD
University of Washington
Kathleen A. Cooney, MD
University of Michigan Comprehensive Cancer Center
Donna S. Neuberg, ScD
Dana-Farber Cancer Institute
Wells A. Messersmith, MD
University of Colorado
Gary K. Schwartz, MD
Memorial Sloan-Kettering Cancer Center
Dawn L. Hershman, MD, MS
Columbia University Medical Center

1:00 PM — 5:30 PM


Poster Discussion Sessions (Discussion Time: 4:30 PM-5:30 PM)

Central Nervous System Tumors

Gastrointestinal (Colorectal) Cancer

Gynecologic Cancer

Leukemia, Myelodysplasia, and Transplantation



2:45 PM — 4:00 PM


Special Session

Pediatric Oncology Award and Lecture

Education Sessions

Around the World in almost 80 Minutes: Lung Cancer Care and Research

Gilberto Schwartsmann, MD, PhD--Chair
Federal University of Rio Grande do Sul
Tony Mok, MD
Prince of Wales Hospital
Tudor-Eliade Ciuleanu, MD
Institute Ion Chiricuta

Controversies in the Adjuvant Treatment of Breast Cancer

Stephen R. D. Johnston, MA, MD, PhD--Chair
Royal Marsden Hospital
Anthony D. Elias, MD
University of Colorado Cancer Center
Hyman Bernard Muss, MD
University of North Carolina Lineberger Comprehensive Cancer Center

Immunotherapy with the T-Cell Checkpoint Antibodies: Implications for the Practitioner

Mario Sznol, MD--Chair
Yale Cancer Center
Jeffrey S. Weber, MD, PhD
H. Lee Moffitt Cancer Center & Research Institute
F. Stephen Hodi, MD
Dana-Farber Cancer Institute

Meet the professor Session

Lessons in Mentorship from a Successful Breast Oncologist (M02)

Gabriel N. Hortobagyi, MD
University of Texas M. D. Anderson Cancer Center



3:45 PM — 6:00 PM


extended Education Sessions

Cancer in Obese Individuals: Optimal Treatment and Beyond

Pamela Jean Goodwin, MD, MSc—Chair
The Mount Sinai Hospital
Rachel Ballard-Barbash, MD, MPH
National Cancer Institute
Jennifer J. Griggs, MD, MPH
University of Michigan
Gary H. Lyman, MD, MPH
Duke University
Melinda Irwin, PhD, MPH
Yale University
Jennifer A. Ligibel, MD
Dana-Farber Cancer Institute

Career Choices in Oncology: Options in Academia, Private Practice, Industry, and Government

Jill Gilbert, MD—Chair
Vanderbilt University
Lillian L. Siu, MD
Princess Margaret Hospital and University of Toronto
C. D. Blanke, MD
University of British Columbia/British Columbia Cancer Agency
Barbara L. McAneny, MD
New Mexico Oncology Hematology Consultants Limited
Richard Pazdur, MD
U. S. Food and Drug Administration
Mace L. Rothenberg, MD
Pfizer Oncology
Fadi S. Braiteh, MD
Comprehensive Cancer Centers of Nevada

Virally Mediated Oncogenesis

Richard F. Ambinder, MD, PhD—Chair
Johns Hopkins School of Medicine
Jürgen C. Becker, MD, PhD
Medical University of Graz
Carole Fakhry, MD, MPH
Johns Hopkins University

Bringing Cancer Genome Sequencing to Clinical Oncology

Matthew Meyerson, MD, PhD—Chair
Dana-Farber Cancer Institute
Arul Chinnaiyan, MD, PhD
University of Michigan Medical Center
Levi Garraway, MD, PhD
Dana-Farber Cancer Institute

4:30 PM — 5:45 PM


Education Sessions

A Fresh Look at Ductal Carcinoma In Situ: Basic Science to Clinical Management

Eun-Sil Shelley Hwang, MD, MPH—Chair
Duke Unversity Medical Center
Victoria Louise Seewaldt, MD
Duke University Medical Center
Beth A. Virnig, PhD
University of Minnesota, School of Public Health

Adaptive Clinical Trial Designs: What Are They and Should They Be Used?

Mary Weber Redman, PhD—Chair
Fred Hutchinson Cancer Research Center
J. Jack Lee, PhD, DDS
University of Texas MD Anderson Cancer Center
Marc E. Buyse, ScD
International Drug Development Institute

Meet the Professor Session

Selection Criteria for Universal Screening and Prevention of Lynch Syndrome (M03)

John Burn, MD
Institute of Genetic Medicine, Newcastle University

Clinical Problems in Oncology Session

Challenging Questions in the Neoadjuvant Management of Breast Cancer (C01)

Erica L. Mayer, MD, MPH—Chair
Dana-Farber Cancer Institute
Emiel J. Rutgers, MD, PhD
Netherlands Cancer Institute
Lori J. Pierce, MD
University of Michigan School of Medicine

Saturday, June 2, 2012

8:00 AM — 9:15 AM

Education Sessions

Costs of Cancer Care: Affordability, Access, and Policy

Thomas J. Smith, MD—Chair
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Richard Sullivan, PhD, MBBS
Kings Health Partners Integrated Cancer Centre
Sean R. Tunis, MD, MSc
Center for Medical Technology Policy

Ethical Challenges of Health Care Reform for Oncology Providers: A Debate

Beverly Moy, MD—Chair
Massachusetts General Hospital
Jeffrey M. Peppercorn, MD, MPH
Duke University Medical Center
Amy Pickar Abernethy, MD
Duke University Medical Center

Molecular and Genomic Diagnostics in Pediatric Oncology: When and How They Should Be Implemented

Stephen L. Lessnick, MD, PhD—Chair
Huntsman Cancer Institute at the University of Utah
Kenneth J. Cohen, MD, MBA
Johns Hopkins School of Medicine
John M. Maris, MD
The Children's Hospital of Philadelphia

New Looks and Challenges for Cooperative Groups

Stephen S. Grubbs, MD—Chair
Helen F. Graham Cancer Center at Christiana Care
Robert Leo Comis, MD
Coalition of Cancer Cooperative Groups
Gregory H. Reaman, MD
Children's National Medical Center

New Options, New Questions: How to Select and Sequence Therapies for Metastatic Melanoma

Michael B. Atkins, MD—Chair
Beth Israel Deaconess Medical Center
Keith T. Flaherty, MD
Massachusetts General Hospital
Jeffrey Alan Sosman, MD
Vanderbilt University Medical Center

Physician Wellness: Coping with Repetitive Loss and Work-Related Stress

Michael Fisch, MD, MPH—Chair
University of Texas M. D. Anderson Cancer Center
Teresa Gilewski, MD
Memorial Sloan-Kettering Cancer Center
Joshua Hauser, MD
Northwestern University

Toward Successful Targeting of the PI3 Kinase Pathway in Cancer

Paul Workman, BSc, PhD, DSc—Chair
The Institute of Cancer Research
John C. Byrd, MD
The Ohio State University Comprehensive Cancer Center and Arthur G. James Cancer Hospital and Solove Research Institute
Carlos L. Arteaga, MD
Vanderbilt University

Meet the Professor Session

Paraganglioma: Genetics in Action (M04)

Joshua David Schiffman, MD
University of Utah

Clinical Problems in Oncology

How and When Molecular Markers Should Be Used in a Neuro-oncology Practice (C02)

Ingo K. Mellinghoff, MD—Chair
Memorial Sloan-Kettering Cancer Center
Martin J. Van Den Bent, MD
ErasmusMC/Daniel den Hoed Cancer Center

8:00 AM — 9:30 AM


Clinical Science Symposia

Cancer Prevention/Epidemiology

Genitourinary Cancer

Gynecologic Cancer

Lung Cancer

8:00 AM — 11:00 AM


Special Session

Designing Clinical Trials for Older Patients: Regulatory, Community and Advocacy Perspectives

8:00 AM — 12:00 PM


General Poster Sessions

Breast Cancer—HER2/ER

Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy

Patient and Survivor Care



8:00 AM — 1:00 PM


Poster Discussion Session (Discussion 12:00 PM-1:00 PM)

Developmental Therapeutics—Clinical Pharmacology and Immunotherapy

Genitourinary (Nonprostate) Cancer

Head and Neck Cancer

Lymphoma and Plasma Cell Disorders

9:30 AM — 10:45 AM


Meet the Professor Session

Management of Brain Metastases in Women with Breast Cancer (M01)

Nancy U. Lin, MD
Dana-Farber Cancer Institute
Naren Ramakrishna, MD, PhD
University of Texas MD Anderson Cancer Center Orlando

9:30 AM — 12:00 PM


Special Session

Opening Session with the Conquer Cancer Foundation Donor Recognition Awards, Fellows of the American Society of Clinical Oncology, Presidential Address, and David A. Karnofsky Memorial Award and Lecture

1:15 PM — 2:30 PM


Education Sessions

Controversies in Prostate Cancer: PSA Screening, Chemoprevention, and Treatment of Early Disease

Barnett S. Kramer, MD, MPH—Chair
National Cancer Institute
Gerald L. Andriole, MD
Washington University School of Medicine
Timothy J. Wilt, MD, MPH
United States Department of Veterans Affairs

Avoiding Overdiagnosis and Overtreatment of Common Cancers

Ian Murchie Thompson, MD—Chair
University of Texas Health Science Center at San Antonio
Ruth D. Etzioni, PhD
University of Washington
Laura Esserman, MD, MBA
University of California, San Francisco Helen Diller Family Comprehensive Cancer Center

Controversies in Myeloma: Induction, Transplant, and Maintenance

Amrita Y. Krishnan, MD—Chair
City of Hope National Medical Center
S. Vincent Rajkumar, MD
Mayo Clinic
Michel Attal, MD
CHU Purpan

Evolving Paradigms in the Management of Unresectable Pancreatic Cancer

Hedy Lee Kindler, MD—Chair
The University of Chicago Medical Center
Theodore S. Hong, MD
Massachusetts General Hospital
Lauren Allison Wiebe, MD
Medical College of Wisconsin

International Variation in Understanding Oncologists' Professional Duties toward Patients, Families, and Themselves

Amy Pickar Abernethy, MD--Chair
Duke University Medical Center
Antonella Surbone, MD, PhD
New York University
Simon Wein, MD
Davidoff Cancer Center, Rabin Medical Center

Thymoma and Thymic Carcinoma: Update on Management

Gregory J. Riely, MD, PhD—Chair
Memorial Sloan-Kettering Cancer Center
Nicolas Girard, MD, MSc
Hopital Louis Pradel
Frank C. Detterbeck, MD
Yale School of Medicine

Upfront Treatment of Ovarian Cancer: International Consensus and Variation

Gordon J. S. Rustin, MD, MBBS—Chair
Mount Vernon Cancer Centre
Deborah Kay Armstrong, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Keiichi Fujiwara, MD, PhD
Saitama Medical University International Medical Center

When Cancer Becomes Personal: The Physician as Patient

Teresa Gilewski, MD—Chair
Memorial Sloan-Kettering Cancer Center
Peter Bach, MD
Memorial Sloan-Kettering Cancer Center
Martin N. Raber, MD
University of Texas M. D. Anderson Cancer Center
George W. Sledge, MD
Indiana University Simon Cancer Center

Meet the Professor Session

Hormone Replacement Therapy: Weighing the Evidence (M06)

Rowan T. Chlebowski, MD, PhD
Harbor-UCLA Medical Center

Clinical Problems in Oncology Session

Toxicity from VEGF and mTOR-Targeted Agents in Renal Cell Carcinoma (C04)

Joaquim Bellmunt, MD, PhD—Chair
University Hospital del Mar-IMIM
Christian K. Kollmannsberger, MD
British Columbia Cancer Agency
Naomi B. Haas, MD
Abramson Cancer Center, University of Pennsylvania



1:15 PM — 2:45 PM


Clinical Science Symposia

Breast Cancer

Central Nervous System Tumors

Developmental Therapeutics

1:15 PM — 4:15 PM


Oral Abstract Session

Pediatric Oncology I

1:15 PM — 5:15 PM


General Poster Sessions

Cancer Prevention/Epidemiology

Central Nervous System Tumors

Head and Neck Cancer

Lung Cancer—Non–Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Lung Cancer—Non–Small Cell Metastatic

1:15 PM — 5:45 PM


Poster Discussion Sessions (Discussion 4:45 PM-5:45 PM)

Breast Cancer—HER2/ER

Developmental Therapeutics—Experimental Therapeutics

Melanoma/Skin Cancers

Sarcoma

3:00 PM — 4:15 PM


Special Sessions

American Cancer Society Award and Lecture

ASCO/Radiological Society of North America (RSNA) Joint Session: New and Upcoming Techniques in Interventional Radiology in Oncology

Michael Paul Link, MD—Co-Chair
Stanford University School of Medicine
Sarah Donaldson, MD—Co-Chair
Stanford Cancer Center
Mark Helvie, MD
University of Michigan
Jean-Francois Geschwind, MD
The Johns Hopkins University School of Medicine

Education Sessions

Mechanisms of Resistance to Targeted Anticancer Agents

Levi A. Garraway, MD, PhD—Chair
Dana-Farber Cancer Institute
Alberto Bardelli, PhD
Istituto Ricerca Cura Cancro and FIRC
Neil P. Shah, MD, PhD
University of California, San Francisco
Alice Tsang Shaw, MD, PhD
Massachusetts General Hospital Cancer Center

Personalized Medicine in Lung Cancer in 2012

Pasi A. Janne, MD, PhD—Chair
Dana-Farber Cancer Institute
Ignacio I. Wistuba, MD
University of Texas M. D. Anderson Cancer Center
Tetsuya Mitsudomi, MD, PhD
Aichi Cancer Center Hospital

Meet the Professor Session

Interpreting the Colorectal Cancer Pathology Report: New and Potentially Overlooked Information (M07)

Carolyn C. Compton, MD, PhD
National Cancer Institute/National Institutes of Health

Clinical Problems in Oncology Session

Clinically Challenging Cases in Acute Myeloid Leukemia (C06)

Dan Douer, MD—Chair
Memorial Sloan-Kettering Cancer Center
Richard A. Larson, MD
The University of Chicago
B. Douglas Smith, MD
The Sidney Kimmel Cancer Center at Johns Hopkins

3:00 PM — 4:30 PM


Clinical Science Symposium

Geriatric Oncology

3:00 PM — 6:00 PM


Oral Abstract Sessions

Gastrointestinal (Noncolorectal) Cancer

Genitourinary (Nonprostate) Cancer

Gynecologic Cancer

Health Services Research

Lymphoma

4:45 PM — 6:00 PM


Education Sessions

Advances in Infection Management in Pediatric Oncology

Andrew Y. Koh, MD—Chair
University of Texas Southwestern Medical Center
Lillian Sung, MD, PhD
The Hospital for Sick Children
Theoklis Zaoutis, MD
Children's Hospital of Philadelphia

Antiemetics: Current Standards, Emerging Approaches, and Persistent Gaps

Ethan M. Basch, MD, MSc—Chair
Memorial Sloan-Kettering Cancer Center
Steven M. Grunberg, MD
Fletcher Allen Health Care
Rebecca Anne Clark-Snow, RN
University of Kansas Cancer Center
Matti S. Aapro, MD
Clinique De Genolier

Meet the Professor Session

Managing Carcinoid Tumors (M08)

Emily K. Bergsland, MD
University of California, San Francisco Helen Diller Family Comprehensive Cancer Center

Clinical Problems in Oncology

Multidisciplinary Management of Unusual Head and Neck Tumors

Louis Benjamin Harrison, MD—Chair
St. Luke's-Roosevelt Hospital and Beth Israel Medical Center, Continuum Cancer Centers of New York
Robert I. Haddad, MD
Dana-Farber Cancer Institute/Harvard Medical School
Joseph A Califano, MD
The Johns Hopkins University School of Medicine

Sunday, June 3, 2012
7:30 AM — 9:00 AM


Special Session

Training Program Directors' Breakfast (Training Program Directors and Associate Training Program Directors Only)

James M. Ford—Chair
Stanford University
Michael P. Kosty, MD
Scripps Clinic
Gregory A. Masters, MD
Thomas Jefferson University Medical School, Medical Oncology Hematology Consultants, PA
Lisa Johnson, MHS, MT(ASCP)SC
American Society of Clinical Oncology
Thomas H. Davis, MD
Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center

8:00 AM — 9:15 AM


Special Session

ASCO/American Association for Cancer Research (AACR) Joint Session: Immunotherapy--A Strategy Whose Time Has (Finally) Come

Michael Paul Link, MD—Co-Chair
Stanford University School of Medicine
Judy Garber, MD, MPH—Co-Chair
Dana-Farber Cancer Institute
Suzanne Louise Topalian, MD
The Johns Hopkins University School of Medicine

Education Sessions

Adjuvant Therapy for Older Patients

Arti Hurria, MD—Chair
City of Hope
Cynthia Owusu, MD, MS
Case Western Reserve University
Nadine Jackson McCleary, MD
Dana-Farber Cancer Institute
Jeffrey Crawford, MD
Duke University Medical Center

Biologic Principles of Targeted Combination Therapy

Johann Sebastian De Bono, MB, ChB, FRCP, MSc, PhD—Chair
Royal Marsden Hospital
Antoni Ribas, MD
University of California, Los Angeles
Geoffrey Shapiro, MD, PhD
Dana-Farber Cancer Institute

Curative-Intent Treatment of Colorectal Cancer Metastases

Leonard Saltz, MD—Chair
Memorial Sloan-Kettering Cancer Center
Stephen Barnett Solomon, MD
Memorial Sloan-Kettering Cancer Center
Steven A. Curley, MD
University of Texas M. D. Anderson Cancer Center

Targeted Therapies in Targeted or Untargeted Sarcomas

Richard F. Riedel, MD—Chair
Duke Cancer Institute, Duke University Medical Center
Andrew J. Wagner, MD, PhD
Dana-Farber Cancer Institute
Robert G. Maki, MD, PhD
Mount Sinai School of Medicine

Meet the Professor Session

Stage I Testicular Cancer Management Options: Surgery, Radiation, Chemotherapy, or Surveillance (M09)

George J. Bosl, MD
Memorial Sloan-Kettering Cancer Center
Carsten Bokemeyer, MD
University Hospital Hamburg

Clinical Problems in Oncology Session

Myelodysplastic Syndrome, Myeloproliferative Neoplasms, and Bone Marrow Failure States (C07)

Jane Apperley, MD—Chair
Hammersmith Hospital
Mikkael A. Sekeres, MD, MS
Department of Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute
Blanche P. Alter, MD, MPH
National Cancer Institute

8:00 AM — 9:30 AM


Highlights of the Day Session

Highlights of the Day I Including Clinical Trials Participation Awards

Clinical Science Symposium

Health Services Research

8:00 AM — 11:00 AM


Oral Abstract Sessions

Breast Cancer—HER2/ER

Central Nervous System Tumors

Head and Neck Cancer

Myeloma

8:00 AM — 12:00 PM


General Poster Sessions

Genitourinary Cancer

Gynecologic Cancer

Melanoma/Skin Cancers

Pediatric Oncology

Sarcoma

8:00 AM — 12:30 PM


Poster Discussion Sessions (Discussion 11:30 AM-12:30 PM)

Cancer Prevention/Epidemiology

Lung Cancer—Non–Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Pediatric Oncology

9:30 AM — 11:30 AM


Special Session

Promoting Faculty Development for Physician Educators

James M. Ford, MD—Chair
Stanford University
John R. Potts, MD
The University of Texas Medical School at Houston
Robert A. Wolff, MD
University of Texas M. D. Anderson Cancer Center

9:45 AM — 11:00 AM


Special Sessions

B. J. Kennedy Award and Lecture for Scientific Excellence in Geriatric Oncology

ASCO/Union for International Cancer Control (UICC) Joint Session: The Changing Paradigm of Cancer Care after the United Nations Summit

Michael Paul Link, MD—Co-Chair
Stanford University School of Medicine
Eduardo L. Cazap, MD—Co-Chair
Latin American-Caribbean Society of Medical Oncology
John Seffrin, PhD
American Cancer Society
David Khayat, MD, PhD
Salpetriere Hospital
Lawrence N. Shulman, MD
Dana-Farber Cancer Institute

Drug Shortages: Why Is This Happening and How Can We Treat Our Patients?

Hagop Kantarjian, MD—Chair
University of Texas M. D. Anderson Cancer Center
Ralph G. Neas, BA, JD
Generic Pharmaceutical Association
Richard L. Schilsky, MD
The University of Chicago

Education Session

Pediatric Oncology Educational Session in Honor of Dr. James Nachman

Stephen Hunger, MD--Chair
University of Colorado Denver School of Medicine
Melissa M. Hudson, MD
St. Jude Children's Research Hospital
Carola A. S. Arndt, MD
Mayo Clinic Rochester

Meet the Professor Session

Treatment of the Patient with Castration-Resistant Prostate Cancer (M10)

Tomasz M. Beer, MD
Oregon Health & Science University Knight Cancer Institute

Clinical Problems in Oncology Session

Challenging Lung Cancer Cases (C08)

Jyoti D. Patel, MD—Chair
Northwestern University
Enriqueta Felip, MD
Vall d'Hebron University Hospital
Karen Kelly, MD
UC Davis Cancer Center

9:45 AM — 12:45 PM


Oral Abstract Sessions

Developmental Therapeutics—Experimental Therapeutics

Gastrointestinal (Colorectal) Cancer

11:30 AM — 12:45 PM


Special Session

Affordability of Cancer Care: A Global Perspective

Eduardo L. Cazap, MD—Co-Chair
Latin American-Caribbean Society of Medical Oncology
Tanja Cufer, MD, PhD—Co-Chair
University Clinic Golnik
Peter Boyle, PhD DSc
International Prevention Research Institute
Ian Tannock, MD, PhD
Princess Margaret Hospital
Richard L. Schilsky, MD
The University of Chicago
Thomas J. Smith, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Education Sessions

Developing a Targeted Therapy: Issues in the Age of Personalized Therapy

Karen A. Gelmon, MD—Chair
British Columbia Cancer Agency
Elizabeth Mansfield, PhD
U. S. Food and Drug Administration
Gwendolyn A. Fyfe, MD
San Francisco, California

Mucosal Injury in Patients with Cancer: Targeting the Biology

Douglas E. Peterson, DMD, PhD—Chair
University of Connecticut Health Center
Dorothy Mary Kate Keefe, MD, MBBS
Royal Adelaide Hospital
Stephen T. Sonis, DMSc, DDS
Biomodels

New Developments in Myeloproliferative Neoplasms

Srdan Verstovsek, MD, PhD—Chair
University of Texas M. D. Anderson Cancer Center
Jason R. Gotlib, MD
Stanford University School of Medicine
Francesco Passamonti, MD
Fondazione IRCCS Policlinico San Matteo

Treatment of Thyroid Cancers: New Information for Medical Oncologists

A. Dimitrios Colevas, MD—Chair
Stanford University School of Medicine
Michael Xing, MD, PhD
The Johns Hopkins University
Manisha H. Shah, MD
The Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute
Keith Christopher Bible, MD, PhD
Mayo Clinic

Meet the Professor Session

Implementing Geriatric Oncology Research in the Cooperative Groups (M11)

Hyman Bernard Muss, MD
University of North Carolina Lineberger Comprehensive Cancer Center
Harvey Jay Cohen, MD
Duke University Medical Center

Clinical Problems in Oncology Session

Management of Uncommon Lymphomas: Primary Mediastinal Large Cell, Mantle, and Peripheral T-Cell Lymphoma (C09)

Steven M. Horwitz, MD—Chair
Memorial Sloan-Kettering Cancer Center
Kerry J. Savage, MD, MSc
British Columbia Cancer Agency
Brad S. Kahl, MD
University of Wisconsin

1:00 PM — 4:00 PM


Plenary Session

Plenary Session Including Science of Oncology Award and Lecture

4:45 PM — 6:00 PM


Education Sessions

A Dickens Tale of the Treatment of Advanced Breast Cancer: The Past, the Present, and the Future

George W. Sledge, MD—Chair
Indiana University Simon Cancer Center
Fatima Cardoso, MD
Breast Unit, Champalimaud Cancer Center
Eric P. Winer, MD
Dana-Farber Cancer Institute
Martine J. Piccart-Gebhart, MD, PhD
Jules Bordet Institute

Addressing the Imbalance of Supply and Demand: Integrating Advanced Practice Providers into Survivorship Care

Michael Goldstein, MD—Chair
Beth Israel Deaconess Medical Center/Harvard Medical School
James Ross Waisman, MD
Breastlink Medical Group Inc
Todd Alan Pickard, PA-C
University of Texas M. D. Anderson Cancer Center
Mary S. McCabe, RN, MA
Memorial Sloan-Kettering Cancer Center

Best Use of Imaging Techniques, Old and New, for Genitourinary Cancers in Clinical Practice

Walter Michael Stadler, MD—Chair
The University of Chicago
Charles J. Ryan, MD
University of California, San Francisco
Josef J. Fox, MD
Memorial Sloan-Kettering Cancer Center

Breast Cancer Chemoprevention: If Not Now, When?

Abenaa M. Brewster, MD, MHS--Chair
University of Texas M. D. Anderson Cancer Center
Nancy E. Davidson, MD
University of Pittsburgh Cancer Institute
Worta J. McCaskill-Stevens, MD
Division of Cancer Prevention, National Cancer Institute

Laboratory and Clinical Insights into Resistance to Tyrosine Kinase Inhibitors

D. Ross Camidge, MD, PhD—Chair
University of Colorado Cancer Center
William Pao, MD, PhD
Vanderbilt-Ingram Cancer Center
Lecia V. Sequist, MD, MPH
Massachusetts General Hospital Cancer Center

Management of Chronic Lymphocytic Leukemia

Neil E. Kay, MD—Chair
Mayo Clinic
Peter Hillmen, PhD
Leeds General Infirmary
John G. Gribben, DSc, MD
St. Bartholomew's Hospital

Medical Errors in Cancer Care: Prevention, Disclosure, and Patient and Family Member Responses

Antonella Surbone, MD, PhD—Chair
New York University
Itzhak Brook, MD, MSc
Georgetown University
Michael Rowe, PhD
Yale School of Medicine

Pontine Gliomas in Children: To Biopsy or Not to Biopsy

Mark W. Kieran, MD, PhD—Chair
Dana-Farber Cancer Institute
Stephanie Puget, MD, PhD
Necker Hospital, Universite Paris-Descartes
Nicholas K. Foreman, MD
The Children's Hospital

Rectal Cancer: New Paradigms beyond Standard Chemotherapy and Radiation

David P. Ryan, MD--Chair
Massachusetts General Hospital Cancer Center
Martin R. Weiser, MD
Memorial Sloan-Kettering Cancer Center
Karyn A. Goodman, MD
Memorial Sloan-Kettering Cancer Center

Short- and Long-term Cardiovascular Complications of Cancer Treatment: Overview for the Practicing Oncologist

Gretchen Genevieve Kimmick, MD, MS—Chair
Duke University Medical Center
Dawn L. Hershman, MD, MS
Columbia University Medical Center
Marianne Ryberg, MD
Herlev University Hospital
Doug Sawyer, MD, PhD
Vanderbilt University

The Oncologist, the Patient, and the Media

Paul R. Helft, MD—Chair
Indiana University Simon Cancer Center
Diane Blum, MSW
Lymphoma Research Foundation
Jeremy Manier
The University of Chicago

Meet the Professor Session

Advanced Cervical Cancer: Going with the Evidence (M12)

David H. Moore, MD
Gynecologic Oncology of Indiana

Clinical Problems in Oncology Session

Chasing Melanoma: Management Issues from Primary Tumor to In Transit Disease (C10)

Vernon K. Sondak, MD—Chair
H. Lee Moffitt Cancer Center & Research Institute
Claus Garbe, MD
University of Tübingen
Leslie Anne Fecher, MD
University of Pennsylvania Abramson Cancer Center
John F. Thompson, MBBS, BSc, MD
Melanoma Institute Australia at Royal Prince Alfred Hospital


Monday, June 4, 2012

8:00 AM — 9:15 AM


Special Session

ASCO/European CanCer Organisation (ECCO) Joint Session

Michael Paul Link, MD—Co-Chair
Stanford University School of Medicine
Cornelis Van De Velde, MD, PhD—Co-Chair
Leiden University Medical Center
Karl Y. Bilimoria, MD, MS
Northwestern University Feinberg School of Medicine
David Dietz, MD
Cleveland Clinic Foundation

Education Sessions

Early Drug Development: Casting a Wide Net versus Preselecting a Narrow Audience

Anthony W. Tolcher, MD—Chair
SouthTexas Accelerated Research Therapeutics (START)
Josep Tabernero, MD
Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology
Bruce Allan Chabner, MD
Massachusetts General Hospital

The Management of Less Common but Complex Upper Gastrointestinal Malignancies: Hepatocellular Carcinoma, Pancreatic Neuroendocrine Tumors and Biliary Tract Tumors

Pamela L. Kunz, MD—Chair
Stanford University Medical Center
Jordan Berlin, MD
Vanderbilt-Ingram Cancer Center
Andrew X. Zhu, MD, PhD
Division of Hematology and Oncology, Massachusetts General Hospital

What the Busy Oncologist Needs to Know about Gastrointestinal Stromal Tumors

Jaap Verweij, MD, PhD—Chair
Erasmus University Medical Center
William D. Tap, MD
University of California, Los Angeles
Michael C. Heinrich, MD
Portland VA Medical Center and Oregon Health & Science University Knight Cancer Institute

Meet the Professor Session

Optimal Use of Hypomethylating Agents and New Strategies (M13)

Alan F. List, MD
H. Lee Moffitt Cancer Center & Research Institute

Clinical Problems in Oncology Session

Integrating Testing for Hereditary Cancer Syndromes in the Oncology Practice (C11)

James M. Ford, MD—Chair
Stanford University Medical Center
Wendy Kohlmann, MS
Huntsman Cancer Institute
Kathleen Blazer, MS
City of Hope

8:00 AM — 9:30 AM


Highlights of the Day Session

Highlights of the Day II

8:00 AM —11:00 AM


Oral Abstract Sessions

Cancer Prevention/Epidemiology

Leukemia, Myelodysplasia, and Transplantation

Lung Cancer—Non–Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

Melanoma/Skin Cancers

Patient and Survivor Care

Pediatric Oncology II

Tumor Biology

8:00 AM — 12:00 PM


General Poster Sessions

Developmental Therapeutics—Clinical Pharmacology and Immunotherapy

Developmental Therapeutics—Experimental Therapeutics

Gastrointestinal (Colorectal) Cancer

Gastrointestinal (Noncolorectal) Cancer

8:00 AM — 12:30 PM


Poster Discussion Session (Discussion 11:30 AM-12:30 PM)

Genitourinary (Prostate) Cancer

9:45 AM — 11:00 AM


Education Sessions

Antibody Conjugates: Targeted Therapy Meets Chemotherapy in One Drug

Howard A. Burris, MD—Chair
The Sarah Cannon Research Institute
John Leonard, MD
Weill Cornell Medical College
James D. Marks, MD, PhD
University of California, San Francisco

Endpoints for Cancer Trials in 2012: Statistical, Regulatory, and Clinical Perspectives (eQ&A)

Daniel J. Sargent, PhD—Chair
Mayo Clinic
Ann T. Farrell, MD
U. S. Food and Drug Administration
Deborah Bruner, PhD, RN
Abramson Cancer Center, University of Pennsylvania

Genomics in Gynecologic Cancers: Important Findings from the Cancer Genome Atlas and Beyond

Douglas A. Levine, MD—Chair
Memorial Sloan-Kettering Cancer Center
Paul J. Goodfellow, PhD
Washington University School of Medicine
Paul Spellman, PhD
Oregon Health & Science University

Key Questions in the Loco-regional Treatment of Breast Cancer

Richard C. Zellars, MD—Chair
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Monica Morrow, MD
Memorial Sloan-Kettering Cancer Center
Thomas A. Buchholz, MD
University of Texas MD Anderson Cancer Center

Meet the Profession Sessions

Current State of the Art in Managing Gastrointestinal Stromal Tumors (M21)

Margaret von Mehren, MD
Fox Chase Cancer Center

Management of Relapsed Refractory Myeloma (M14)

Kenneth Carl Anderson, MD
Dana-Farber Cancer Institute

11:30 AM — 12:45 PM


Education Sessions

Genetics, the Environment, and Cancer Risk: The Case for Melanoma, Colon, and Lung Cancer

Sancy Ann Leachman, MD—Chair
University of Utah Hospitals and Clinics
Martha L. Slattery, PhD
University of Utah
Margaret R. Spitz, MD
University of Texas MD Anderson Cancer Center

Glioblastoma: Taking the Standard of Care to the Cutting Edge

Mark R. Gilbert, MD—Chair
University of Texas M. D. Anderson Cancer Center
Daniel Brat, MD, PhD
Emory University
Howard Colman, MD, PhD
University of Utah

Lung Cancer Screening 101

Christine D. Berg, MD—Chair
National Cancer Institute
Denise R. Aberle, MD
University of California, Los Angeles David Geffen School of Medicine
Douglas E. Wood, MD
University of Washington

New Diagnostics and Devices in the Era of Comparative Effectiveness

Daniel F. Hayes, MD—Chair
University of Michigan Medical Center
Muin Khoury, MD, PhD
Office of Public Health Genomics, Centers for Disease Control and Prevention
David Ransohoff, MD
University of North Carolina, Chapel Hill

Possible Impact of the Proposed Changes to the Common Rule on Clinical Trial Practice (eQ&A)

Jerry Menikoff, MD, JD—Chair
U. S. Department of Health & Human Services
Donald A. Berry, PhD
University of Texas MD Anderson Cancer Center
Carolyn C. Compton, MD, PhD
National Institutes of Health

Stage III Colon Cancer: What Works, What Doesn't and Why, and What's Next (eQ&A)

Thierry Andre—Chair
Pitie-Salpetriere Hospital
Bert H. O'Neil, MD
University of North Carolina at Chapel Hill
Jeffrey A. Meyerhardt, MD, MPH
Dana-Farber Cancer Institute

The ASCO Quality Oncology Practice Initiative and Beyond

Joseph O. Jacobson, MD—Chair
North Shore Medical Center
Michael N. Neuss, MD
Oncology/Hematology Care, Inc.
Robert Hauser, PhD, PharmD
American Society of Clinical Oncology

The Many Options for Breast Imaging: What to Use When

Chris Flowers, MD—Chair
H. Lee Moffitt Cancer Center & Research Institute
Karla Kerlikowske, MD
University of California, San Francisco
Maxine S. Jochelson, MD
Memorial Sloan-Kettering Cancer Center

Meet the Profession Sessions

A Multidisciplinary Approach to Integrating Local Therapies with Systemic Approach in Soft Tissue Sarcomas (M22)

Raphael E. Pollock, MD, PhD
University of Texas MD Anderson Cancer Center

Immune-Related Adverse Events (IrAEs) of CTLA-4 Blockade: Patient Selection, Recognition, and Management of IrAEs (M15)

F. Stephen Hodi, MD
Dana-Farber Cancer Institute

11:30 AM — 1:00 PM


Clinical Science Symposia

Head and Neck Cancer

Lymphoma and Plasma Cell Disorders

Pediatric Oncology

1:15 PM — 2:30 PM


Special Session

ASCO/Society of Nuclear Medicine (SNM) Joint Session: PET Criteria for Response Assessment and Timing of the Scans

Michael Paul Link, MD—Co-Chair
Stanford University School of Medicine
Andrei Iagaru, MD—Co-Chair
Stanford University
Homer A Macapinlac, MD
University of Texas M. D. Anderson Cancer Center
Erik Mittra, MD, PhD
Stanford University School of Medicine

Education Sessions

Global Variations in Access to New Therapies for Sarcomas and Gastrointestinal Stromal Tumors

George D. Demetri, MD—Chair
Dana-Farber Cancer Institute and Harvard Medical School
Stefan Sleijfer, MD, PhD
Department of Medical Oncology, Erasmus University Medical Center Daniel den Hoed Cancer Center
Ian Robert Judson, MD
The Royal Marsden NHS Foundation Trust

How to Manage Very Rare Pediatric Cancers

Alberto S. Pappo, MD—Chair
St. Jude Children's Research Hospital
Fariba Navid, MD
St. Jude Children's Research Hospital
Stephen Skapek, MD
The University of Chicago

Overcoming Disparities in Clinical Trial Accrual Among African Americans

Sandra M. Swain, MD—Chair
Washington Hospital Center
Jean Ford, MD
Johns Hopkins
Deliya Banda, PhD, MPH
Washington Hospital Center
Worta J. McCaskill-Stevens, MD
National Cancer Institute

Perspectives on Headline-Making News in Neuro-oncology

Timothy Francis Cloughesy, MD—Chair
University of California, Los Angeles
E. Antonio Chiocca, MD, PhD
Ohio State University Medical Center
Philip H. Gutin, MD
Memorial Sloan-Kettering Cancer Center

Recent Clinical Highlights in Gynecologic Oncology

Lynette Denny, MD, PhD—Chair
University of Cape Town
D. Scott McMeekin, MD
University of Oklahoma Health Sciences Center
Nicoletta Colombo, MD
University of Milan-Bicocca

Recent Innovations in the Management of Genitourinary Cancers (eQ&A)

Matt D. Galsky, MD—Chair
The Tisch Cancer Institute, Mount Sinai School of Medicine
Elisabeth I. Heath, MD
Karmanos Cancer Institute, Wayne State University
Robert John Motzer, MD
Memorial Sloan-Kettering Cancer Center

Talking in Sync with Patients across Cultural Barriers

Lidia Schapira, MD—Chair
Massachusetts General Hospital
William J. Hicks, MD
The Ohio State University
Louise Villejo, MPH
University of Texas MD Anderson Cancer Center

Targeting Critical Molecular Aberrations Early in the Course of Solid Tumors: Is It about Time?

Razelle Kurzrock, MD—Chair
University of Texas M. D. Anderson Cancer Center
Hagop Kantarjian, MD
University of Texas MD Anderson Cancer Center
Laura Esserman, MD, MBA
University of California, San Francisco Helen Diller Family Comprehensive Cancer Center

Update of the Oxford Overview: New Insights and Perspectives in the Era of Personalized Medicine

Harold J. Burstein, MD, PhD—Chair
Dana-Farber Cancer Institute
Kathleen I. Pritchard
Sunnybrook Odette Cancer Centre and the University of Toronto
Carl Bergh, MD
Karolinska Institutet, University Hospital

Using Social Media in Oncology for Education and Patient Engagement (eQ&A)

Anas Younes, MD—Chair
University of Texas M. D. Anderson Cancer Center
Michael A. Thompson, MD, PhD
ProHealth Regional Cancer Center
Robert Stephen Miller, MD
Johns Hopkins Oncology Center

Meet the Professor Sessions

Bringing Personalized Cancer Therapy into Routine Use (M23)

John Mendelsohn, MD
University of Texas MD Anderson Cancer Center

Cutaneous Squamous Cell Carcinoma and Basal Cell Carcinoma: Beyond Surgery (M16)

Caroline Robert, MD, PhD
Cancer Institute Gustave Roussy

1:15 PM — 5:15 PM


General Poster Sessions

Health Services Research

Leukemia, Myelodysplasia, and Transplantation

Lymphoma and Plasma Cell Disorders

Tumor Biology

1:15 PM — 5:45 PM


General Poster Sessions (Discussion 4:45 PM-5:45 PM)

Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy

Gastrointestinal (Noncolorectal) Cancer

Patient and Survivor Care

3:00 PM — 4:15 PM


Special Session

ASCO/American Society of Hematology (ASH) Joint Session

Michael Paul Link, MD—Co-Chair
Stanford University School of Medicine
Armand Keating, MD—Co-Chair
Princess Margaret Hospital

Education Sessions

Castration-Resistant Prostate Cancer: New Insights into Biology and Treatment (eQ&A)

A. Oliver Sartor, MD—Chair
Tulane Cancer Center
Robert Evan Reiter, MD
University of California, Los Angeles
Andrew J. Armstrong, MD, ScM
Duke Cancer Institute

Doing It Right, and for Less: Implementing Practice Changes to Manage the Growing Complexities, Inefficiencies, and Costs of Cancer Care

Adam Brufsky, MD, PhD—Chair
University of Pittsburgh School of Medicine
Bruce E. Hillner, MD
Virginia Commonwealth University
Henry Orlando Otero, MD
Virginia Mason Medical Center

Gene Patenting: Effects on Biotechnology and Oncology

Kenneth Offit, MD, MPH—Chair
Memorial Sloan-Kettering Cancer Center
Roger David Klein, MD, JD
Bloodcenter of Wisconsin
Hans Sauer, PhD, JD
Biotechnology Industry Organization

Liver-Directed Therapeutic Options for Hepatocellular Carcinoma: Patient Selection and Clinical Outcomes

Laura A. Dawson, MD—Chair
Princess Margaret Hospital
Kenneth Tanabe, MD
Massachusetts General Hospital Cancer Center
Fred T. Lee, MD
University of Wisconsin

Optimizing Efficient and Effective Care of Cancer Survivors

Eva Grunfeld, MD, DPhil—Chair
University of Toronto
Craig Earle, MD
Institute for Clinical Evaluative Sciences
Paul Han, MD, MA, MPH
Maine Medical Center Reseach Institute

Transition and Decision Making for Palliative Care of Patients with Pediatric Cancer

Jennifer W. Mack, MD—Chair
Dana-Farber Cancer Institute
Chris Feudtner, MD, PhD, MPH
Children's Hospital of Philadelphia
Pamela S. Hinds, PhD, RN
Children's National Medical Center

Treatment of Older Patients with Advanced Cancer: Balancing Efficacy with Toxicity (eQ&A)

Supriya Gupta Mohile, MD, MS—Chair
University of Rochester Medical Center
Heidi D. Klepin, MD, MS
Wake Forest School of Medicine
Arati Rao, MD
Duke University Medical Center/Durham Veterans Affairs Medical Center

Meet the Professor Sessions

Assessing Patients' Psychosocial Well-Being in Clinical Practice: Practical Considerations (M17)

Paul B. Jacobsen, PhD
H. Lee Moffitt Cancer Center & Research Institute

Developing Patient-Centered Quality Metrics in Oncology Care: Where We Are and Where We're Going (M20)

Christopher S. Lathan, MD, MS, MPH
Dana-Farber Cancer Institute

3:00 PM — 4:30 PM


Clinical Science Symposium

Melanoma

3:00 PM — 6:00 PM


Oral Abstract Sessions

Developmental Therapeutics—Clinical Pharmacology and Immunotherapy

Lung Cancer—Non–Small Cell Metastatic

Sarcoma

4:45 PM — 6:00 PM


Special Session

ASCO/Children's Oncology Group (COG) Joint Session: ASCO/Children's Oncology Group (COG) Joint Session: The Risks-Benefits of Cardioprotection in Children with Cancer

Michael Paul Link, MD—Co-Chair
Stanford University School of Medicine
Peter C. Adamson, MD--Co-Chair
Children's Hospital of Philadelphia
Stephen E. Sallan, MD
Dana-Farber Cancer Institute
Rudolf K. Steiner, MD
University of Zurich
Ralf Herold, MD
European Medicines Agency

Education Sessions

Angiogenic Targeting after 10 Years of Clinical Trials and Practice (eQ&A)

Michael L. Maitland, MD, PhD—Chair
The University of Chicago
Lee S. Rosen, MD
UCLA Division of Hematology-Oncology
Lee M. Ellis, MD
University of Texas MD Anderson Cancer Center

Genomic Cancer Risk Assessment: A Translational Challenge

Zsofia Kinga Stadler, MD—Chair
Memorial Sloan-Kettering Cancer Center
Stephen B. Gruber, MD, PhD, MPH
University of Michigan
Fergus J. Couch, PhD
Mayo Clinic

Patient Portals in Oncology

Elizabeth Schmidt Rodriguez, RN—Chair
Memorial Sloan-Kettering Cancer Center
Henry Feldman, MD
Division of Clinical Informatics

Meet the Professor Session

Lessons Learned in Drug Development for Children with Cancer (M18)

Gregory H. Reaman, MD
Children's Oncology Group


Tuesday, June 5, 2012

8:00 AM — 9:15 AM


Education Sessions

"Personalized" Oncology for Colorectal Cancer: Ready for Prime Time or Stop the Train

Alan Paul Venook, MD—Chair
University of California, San Francisco
Johanna C. Bendell, MD
The Sarah Cannon Research Institute
Robert S. Warren, MD
University of California, San Francisco

Imaging in Neuro-oncology: Practical Primer for the Practicing Physician

Susan Marina Chang, MD—Chair
University of California, San Francisco
Whitney Pope, MD, PhD
University of Califonia, Los Angeles
Andrew David Norden, MD, MPH
Dana-Farber Cancer Institute

Kidney Cancer Biology and Therapeutics: VEGFR, mTOR, and Beyond

Toni K. Choueiri, MD—Chair
Dana-Farber Cancer Institute, Harvard Medical School
William G. Kaelin, MD
Dana-Farber Cancer Institute
Daniel Yick Chin Heng, MD, MPH
Tom Baker Cancer Centre, University of Calgary

Molecular Pathways for the Practicing Pediatric Oncologist

Donald W. Parsons, MD, PhD—Chair
Texas Children's Hospital
Katia Scotlandi, PhD
Istituto Ortopedico Rizzoli
Tobey MacDonald, MD
Emory University

Patients with HPV-Positive Oropharynx Tumors: Communicating Diagnosis to Family and Treatment Options

David M. Brizel, MD—Chair
Duke University Medical Center
William H. Westra, MD
Johns Hopkins School of Medicine
Maura L. Gillison, MD, PhD
The Ohio State University

8:00 AM — 9:30 AM


Highlights of the Day Session

Highlights of the Day III

8:00 AM — 12:30 PM


Poster Discussion Sessions (Discussion 11:30 AM-12:30 PM)

Health Services Research

Lung Cancer—Non–Small Cell Metastatic

Tumor Biology

9:45 AM — 11:00 AM


Education Sessions

Breaching the Castle Wall: The Blood-Brain Barrier

William F. Elmquist, PhD, PharmD—Chair
University of Minnesota
John F. Deeken, MD
Lombardi Comprehensive Cancer Center, Georgetown University
Patricia LoRusso, DO
Karmanos Cancer Institute

Genetic Counseling of the Patient with Pediatric Cancer

Joshua David Schiffman, MD—Chair
University of Utah
Kim Nichols, MD
Childrens Hospital of Philadelphia
Sara Knapke, MS
Cincinnati Children's Hospital Medical Center

Global Perspective of Locally Advanced Gastric Cancer: Different Treatment Paradigms and Their Rationale

Manish A. Shah, MD—Chair
Weill Cornell Medical College
Sam S. Yoon, MD
Massachusetts General Hospital
Yoon-Koo Kang, MD, PhD
Department of Oncology, Asan Medical Center

Leveraging Virtual Patient Communities for Optimal Clinical Care and Research

Howard Jack West, MD—Chair
Swedish Cancer Institute
George D. Demetri, MD
Dana-Farber Cancer Institute and Harvard Medical School
Dave Debronkart
Boston, Massachusetts

Translating Biologic Discoveries into Clinical Trials

Lisa F. Licitra, MD—Chair
Fondazione IRCCS Istituto Nazionale dei Tumori
Christine H. Chung, MD
Johns Hopkins University
Lillian L. Siu, MD
Princess Margaret Hospital and University of Toronto



9:45 AM — 11:15 AM


Clinical Science Symposium

Patient and Survivor Care



9:45 AM — 12:45 PM


Oral Abstract Sessions

Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy

Genitourinary (Prostate) Cancer

1 Jun - 5 Jun 2012
Chicago
United States of America
meeting website